Sandoz targets 70% price cut for weight-loss drugs in Canada
Generic drugmaker is preparing cheaper alternatives for when patents expire in the country next year
Related reading
US to slash prices of obesity drugs offered on Trump website
White House’s landmark deal with Novo Nordisk and Eli Lilly will cut costs from at least $1,000 to about $350
Indian weight-loss market becomes ‘bloodbath’ as drugmakers pile in
Consumers await cheaper generics after expiry of patent for Ozempic ingredient
Pharma just ‘scratching the surface’ of weight-loss drug market
Novo Nordisk chief estimates industry reaching only 15% of potential customers at most
Trump administration slashes Ozempic and Wegovy price for Medicare
US negotiates 71% cost reduction of Novo Nordisk’s obesity drugs for elderly Americans on government health insurance
Weight-loss wars: $10bn hostile battle pits Pfizer against Novo Nordisk
Two groups fight for edge in one of the most lucrative drug classes in pharmaceutical industry history
Novo Nordisk faces more gloom from price cuts in crowded anti-obesity drugs…
Danish group’s challenges mount despite winning reprieve after Hims & Hers withdraws plan to sell copycat Wegovy pill